N, S., JSL, L., TE, M., O, S., YB, C., RCH, N., . . . B, C. (2016). Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients. Clinical pharmacokinetics, 55(10), 1239. https://doi.org/10.1007/s40262-016-0402-7
Chicago Style (17th ed.) CitationN, Sutiman, et al. "Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients." Clinical Pharmacokinetics 55, no. 10 (2016): 1239. https://doi.org/10.1007/s40262-016-0402-7.
MLA (9th ed.) CitationN, Sutiman, et al. "Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients." Clinical Pharmacokinetics, vol. 55, no. 10, 2016, p. 1239, https://doi.org/10.1007/s40262-016-0402-7.